A randomized, partially-blinded, single-dose, 4-way crossover study to evaluate the efficacy, safety, tolerability and pharmacokinetics of orally inhaled indacaterol maleate administered via the Concept1 device or as a PulmoSphere® formulation via the Simoon device.
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2012
At a glance
- Drugs Indacaterol; Indacaterol
- Indications Asthma
- Focus Therapeutic Use
- 14 Apr 2012 Official Title amended as reported by European Clinical Trials Database record.
- 06 May 2010 Additional trial locations identified as reported by ClinicalTrials.gov.
- 06 May 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.